Generics US generic major Mylan today confirmed that a federal district court has granted its request to enforce a settlement agreement between Endo Pharmaceuticals, part of Endo Health Solutions, and Mylan on patent litigation in connection with Mylan's filing of an Abbreviated New Drug Application) for frovatriptan succinate, a generic version of Endo’s Frova, which is used to treat acute migraine headaches in adults. 11 April 2014